Science

Science

In recent years, progress in anti-cancer therapeutics based on monoclonal antibodies, checkpoint inhibitors and CAR T cell-based immunotherapies has delivered significant success.  Alphageneron’s mission is to deliver best-in-class ‘living’ drugs for a wide range of cancers and viral diseases. We believe that our unique NK cell-based therapeutics will deliver significant success and play a pivotal role in the treatment of cancer and viral infections.